Harvard Bioscience's total assets for Q3 2025 were $77.99M, a decrease of -2.62% from the previous quarter. HBIO total liabilities were $63.92M for the fiscal quarter, a -0.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.